CSI Market
Sign In | Register

Bioceres Crop Solutions (BIOX) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access BIOX Annual Income Statement →
Income statement data covering Bioceres Crop Solutions–Jun 30 2024 offers a view into how Jun 30 2025's operating results have moved alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2025)
Q4 2025 		0 0 0 (Jun 30 2024)
Revenues
Revenue From Contracts With Customers73.67
Total Revenue73.81
Costs & Expenses
Cost of Goods and Services Sold47.15
Gross Profit128.79
Selling, Administration, Marketing123.11
Research and Development Expense14.91
OtherOperating Income Expense0.05
Total operating costs including COS66.28
Operating income / -loss7.52
Net Interest Expense / -Income0.00
Other loss / -income0.00
Total costs & expenses389.79
Income & Taxes
Income / -loss before income taxes-1.37
Income taxes expenses / -benefit3.11
Income after income taxes-8.95
Net income / -loss of other equity0.00
Income / -loss from continuing operations-182.47
Non-controlling interests-3.43
Net income / -loss-182.47
Income / -loss to shareholder-182.47
EBIT-1.37
EBITD3.09
EBITDA11.00
Earnings Per Share
Basic EPS (excl. extra items)-0.08
Extraordinary items-2.80
Basic Net EPS-2.88
Basic shares outstanding (Mill. of Units)63.48
Diluted Net EPS-2.88
Diluted average shares (Mill. of Units)63.48
4 historic quarters locked

Sign in to unlock the full Bioceres Crop Solutions income statement history.

Sign In Create Free Account

About BIOX Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.